How to Buy Johnson & Johnson Stock
Johnson & Johnson
Johnson & Johnson is a general drug manufacturer company located in New Jersey, United States, which is part of the Healthcare sector, and is traded under the ticker JNJ on the NYSE exchange.
Johnson & Johnson stock last closed at $157.10, up 0.28% from the previous day, and has increased 8.01% in one year. It has overperformed other stocks in the Drug Manufacturers - General industry by 0.16 percentage points. Johnson & Johnson stock is currently +11.67% from its 52-week low of $140.68, and -7.58% from its 52-week high of $169.99.
As of Jun 13, 2025, there are 2.41B shares of JNJ outstanding. The market capitalization of JNJ is $377.99B. In the last 24 hours, 6.59M JNJ shares were traded.
How to Buy Johnson & Johnson Stock
Not sure how to invest in Johnson & Johnson stock? Here's how.
- Figure out where to buy Johnson & Johnson stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you figure out where to buy Johnson & Johnson stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Select your method of payment and add your details.
- Evaluate Johnson & Johnson stock: The Johnson & Johnson ticker symbol is JNJ. Is Johnson & Johnson stock a good investment? Should you buy shares of JNJ? How do JNJ's underlying business fundamentals look? Do top analysts think Johnson & Johnson is a good buy? Why has JNJ's stock price moved recently? (Hint: Our stock research website can help you understand if JNJ is a good stock to buy).
- Make your JNJ purchase: Decide if you will purchase JNJ shares at the current market price or use a limit order to purchase JNJ shares at a particular price.
- Watch your investment in JNJ: Create a watchlist to the latest updates on your investment in Johnson & Johnson stock.
Step 1: Figure out where to buy Johnson & Johnson stock
You need a brokerage account in order to access the NYSE market and buy JNJ stock.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global financial markets: From Tech to Financial Services, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected the best brokerage, you'll need to fill out some personal details so you can invest in JNJ stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open a new brokerage account.
- Submit your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've filled out your info on one of the best stock trading apps, you can securely and quickly fund your account:
Watch the video below if you need help transferring money into your brokerage account.
Step 4: Evaluate Johnson & Johnson stock
After you have identified the best place to buy Johnson & Johnson stock, it's crucial to evaluate their stock before you buy, so you truly comprehend the risk as well as the upside.
Johnson & Johnson Metrics
Johnson & Johnson Overview
WallStreetZen was created to help average investors perform better fundamental analysis.
You can see all of the due diligence checks on JNJ's stock page.
Is JNJ stock undervalued?
Analysts use many financial metrics, analyses, models, and charts to gauge JNJ's fair value.
Using relative valuations measures:
- JNJ could be undervalued based on its P/E ratio of 17.34x, relative to Drug Manufacturers - General industry P/E ratio of 39.4x
- JNJ could be undervalued based on its P/B ratio of 4.84x, relative to Drug Manufacturers - General industry P/B ratio of 6.12x
- JNJ could be overvalued based on its PEG ratio of 1.93x
You can do more valuation analysis on JNJ's stock here.
JNJ Financial Health Overview
Passed Health Checks:
- There are more short-term assets than short-term liabilities on the JNJ balance sheet.
- Total JNJ debt is lower than 5 years ago, relative to shareholder equity.
- JNJ's operating cash flow of $24.78B allows it to safely service it's debt of $52.25B.
- JNJ earnings of $27.41B is not sufficient to cover its interest payments.
- There are more short-term assets than long-term liabilities on the JNJ balance sheet.
Failed Health Checks:
- JNJ has a relatively high debt to equity ratio of 1.48.
- JNJ profit margin has gone down from 44.9% to 24.4% in the past year.
Is Johnson & Johnson stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 10 sell side analysts who track JNJ, the consensus analyst rating on JNJ is a Hold
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
Latest JNJ Analyst Forecasts
Tim Anderson, a top 28% analyst from Bank of America maintains JNJ with a hold rating and lowers their JNJ price target from $171.00 to $159.00, on Apr 10, 2025.
Bank of America's Tim Anderson lowered their price target on Johnson & Johnson (NYSE: JNJ) by 7% from $171 to $159 on 2025/04/10. The analyst maintained their Hold rating on the stock.
Johnson & Johnson will report its Q1 2025 earnings on 2025/04/15.
In spite of an unchanged overall revenue projection, Anderson revised their gross margins and operation expense estimates, resulting in a 2% decrease in EPS for Q1.
For FY 2025, the analyst predicted a 2% increase in total revenue and a 1% decrease in underlying EPS.
Anderson reported that their reduced price target reflects the new, lower EPS expectations for 2025 and the recent decrease in the pharmaceutical group's P/E ratio as a result of tariff fears.
Asad Haider, a bottom 47% analyst from Goldman Sachs upgrades JNJ to a strong buy rating and raises their JNJ price target from $157.00 to $172.00, on Apr 9, 2025.
Vamil Divan, a top 5% analyst from Guggenheim maintains JNJ with a hold rating and raises their JNJ price target from $162.00 to $166.00, on Feb 3, 2025.
Rick Wise, a top 9% analyst from Stifel Nicolaus maintains JNJ with a hold rating and lowers their JNJ price target from $170.00 to $155.00, on Jan 23, 2025.
Larry Biegelsen, a top 15% analyst from Wells Fargo maintains JNJ with a hold rating and lowers their JNJ price target from $166.00 to $152.00, on Jan 23, 2025.
You can dig deeper into what analysts are projecting on the Johnson & Johnson stock forecast page.
JNJ Trading Indicators
JNJ Performance Metrics
Last year, JNJ earnings were $21.81B. In the past 5 year, JNJ's earnings have gone up by 6.83% per year. This was slower than the Drug Manufacturers - General industry average of 7.53%.
Last year, JNJ revenue was $89.33B. In the past five year, JNJ's revenue has increased by 1.55% per year. This was slower than the Drug Manufacturers - General industry average of 9.71%.
Dive into JNJ's earnings and revenue performance here.
What are JNJ insiders up to?
In the last year, insiders at JNJ have sold more shares than they have bought.
John C. 1. Reed, EVP Innovative Medicine RD of JNJ, was the latest JNJ insider to sell. They sold $1,719,722.62 worth of JNJ stock on May 1, 2025.
Learn more about who owns JNJ shares here.
Can I rely on JNJ as an income stream?
Johnson & Johnson pays a dividend of 3.2%, compared to the Drug Manufacturers - General industry's average dividend yield of 3.41%. If you owned $1,000 worth of JNJ stock, you would have been paid $31.95 last year.
Johnson & Johnson dividend payments have consistently grown over the past decade and have remained stable.
Get more info about Johnson & Johnson dividend yield and history here.
What others are saying about JNJ
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Make your JNJ purchase
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally sufficient. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at an exact price, place a limit order.
Click the Open Trade button and your broker will place the order.
If you require more help with buying stocks on eToro, watch the helpful video below:
Step 6: Watch your investment in JNJ
Now that you own some JNJ stock, you'll want to stay up-to-date on your investment.
Create a watchlist to track your JNJ stock.
JNJ Feed
How to Buy Stock in Johnson & Johnson
To summarize, here are the 6 steps for buying Johnson & Johnson stock:
- Figure out where to buy Johnson & Johnson stock
- Open your brokerage account
- Deposit funds into your investment account
- Evaluate Johnson & Johnson stock
- Make your JNJ purchase
- Watch your investment in JNJ
If you require a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to monitor your investment in Johnson & Johnson, get started below.
More Articles You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.